DK0662975T3 - - Google Patents

Info

Publication number
DK0662975T3
DK0662975T3 DK93921304.7T DK93921304T DK0662975T3 DK 0662975 T3 DK0662975 T3 DK 0662975T3 DK 93921304 T DK93921304 T DK 93921304T DK 0662975 T3 DK0662975 T3 DK 0662975T3
Authority
DK
Denmark
Prior art keywords
adenosine
vitro
physiological effects
receptor activity
act
Prior art date
Application number
DK93921304.7T
Other languages
Danish (da)
English (en)
Inventor
Norton P Peet
Nelsen L Lentz
David R Borcherding
Philip M Weintraub
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0662975T3 publication Critical patent/DK0662975T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK93921304.7T 1992-09-30 1993-09-02 DK0662975T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95418092A 1992-09-30 1992-09-30

Publications (1)

Publication Number Publication Date
DK0662975T3 true DK0662975T3 (el) 1997-04-28

Family

ID=25495051

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93921304.7T DK0662975T3 (el) 1992-09-30 1993-09-02

Country Status (19)

Country Link
EP (1) EP0662975B1 (el)
JP (1) JPH08502069A (el)
KR (1) KR100316354B1 (el)
AT (1) ATE150761T1 (el)
AU (1) AU672226B2 (el)
CA (1) CA2145682C (el)
DE (1) DE69309293T2 (el)
DK (1) DK0662975T3 (el)
ES (1) ES2102679T3 (el)
FI (1) FI109129B (el)
GR (1) GR3023761T3 (el)
HU (1) HU220760B1 (el)
IL (2) IL107101A0 (el)
MX (1) MX9306032A (el)
NO (1) NO303875B1 (el)
NZ (1) NZ256195A (el)
TW (1) TW302367B (el)
WO (1) WO1994007905A1 (el)
ZA (1) ZA937108B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921753B2 (en) 2000-06-27 2005-07-26 Pfizer Inc Purine derivatives
GB0015727D0 (en) * 2000-06-27 2000-08-16 Pfizer Ltd Purine derivatives
GB0022695D0 (en) 2000-09-15 2000-11-01 Pfizer Ltd Purine Derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives

Also Published As

Publication number Publication date
TW302367B (el) 1997-04-11
HU9500918D0 (en) 1995-05-29
AU4844693A (en) 1994-04-26
MX9306032A (es) 1994-03-31
CA2145682C (en) 1998-11-10
NO951213L (no) 1995-03-29
IL107101A0 (en) 1993-12-28
NO303875B1 (no) 1998-09-14
FI109129B (fi) 2002-05-31
EP0662975B1 (en) 1997-03-26
EP0662975A1 (en) 1995-07-19
AU672226B2 (en) 1996-09-26
NO951213D0 (no) 1995-03-29
CA2145682A1 (en) 1994-04-14
WO1994007905A1 (en) 1994-04-14
ATE150761T1 (de) 1997-04-15
GR3023761T3 (en) 1997-09-30
DE69309293T2 (de) 1997-07-10
HUT72611A (en) 1996-05-28
DE69309293D1 (de) 1997-04-30
ES2102679T3 (es) 1997-08-01
FI951500A (fi) 1995-03-29
HU220760B1 (hu) 2002-05-28
JPH08502069A (ja) 1996-03-05
ZA937108B (en) 1994-05-17
NZ256195A (en) 1996-05-28
KR950703572A (ko) 1995-09-20
KR100316354B1 (ko) 2002-09-26
IL107101A (en) 2000-07-16
FI951500A0 (fi) 1995-03-29

Similar Documents

Publication Publication Date Title
AU1259288A (en) Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids)
CA2013380A1 (en) Selective adenosine receptor agents
GR3003388T3 (en) Imidazolylguanidine derivatives, process for their preparation and medicines containing them
DK0662975T3 (el)
ES2107431T3 (es) Agentes con accion selectiva sobre los receptores de la adenosina.
IL86077A0 (en) Receptor of the small rhinovirus receptor group,its preparation and pharmaceutical compositions containing it
CA2013381A1 (en) Selective adenosine receptor compounds
EP0320207A3 (en) Methods and compositions for activating the human insulin receptor kinase
MX9403382A (es) Xantinas sustituidas en la posicion 8 como agentes receptores selectivosde adenosina.
AU7111587A (en) Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use
Ganesalingam MAXIMUM LIKELIHOOD APPROACH TO CLUSTERING
HU910063D0 (en) Process for the production of preparations containing synergetic combination of active agents of natural origin, usable for selective decreasing of blood lipoids
UA9742A (uk) Спосіб прогнозування ризику раптової смерті у хворих на суправентрикулярні тахіаритмії на тлі додаткових шляхів проведення
GR1002968B (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος.
SE8702193D0 (sv) Insatspase engangs for blod, infusion och spolvetskor
MX9800981A (es) Promotor del gen de endoglina humana y su uso.